Skip to content
Search

Latest Stories

Covid-19 cost claims: Less than three weeks left for contractors

The Pharmaceutical Services Negotiating Committee (PSNC) will host a second Covid-19 cost claims workshop for community pharmacy contractors on Monday (August 2) at 7.30 pm.

During the online workshop, PSNC’s CEO and Director of Pharmacy Funding will explain the deal reached with HM government, describe the NHSBSA claiming process, and work through some examples.


Community pharmacy contractors have less than three weeks left to claim for the extra costs they incurred due to the Covid-19 pandemic.

Under the deal reached between PSNC and HM government, Covid-19 cost claims must be made between 5th July and 15th August 2021 using an agreed claim form provided by the NHS Business Services Authority (NHSBSA), and payments will be made on 1st October 2021.

Contractors can claim for specific categories of Covid-19 related costs incurred between 1st March 2020 and 31st March 2021 for the delivery of NHS pharmaceutical services.

The NHSBSA claim form asks contractors to set out their costs according to these categories and to indicate the evidence they have for them.

The Department of Health and Social Care (DHSC) has not set out detailed evidence requirements so this will need careful thought, particularly as contractors will also need to provide documentation to evidence their claims should the NHSBSA ask to see it.

"It is important that no contractor misses out on this opportunity, so please begin thinking about your Covid-19 costs and gathering evidence for them as soon as possible so you have adequate time to complete the claim form," said PSNC.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less